The DOI matches its Crossref record.
Evaluation of the Biochemical Targets of Genistein in Tumor Cells
Open accessAbstract
Although data from epidemiological studies and cancer models suggest that genistein plays an important role in cancer prevention, the biochemical target(s) of genistein action is (are) not known. Genistein is a potent in vitro inhibitor of protein tyrosine kinase (PTK) activity, especially that of the epidermal growth factor receptor (EGF-R), having little effect on serine/threonine kinases. This led to the suggestion that genistein might exert its anti-cancer effects through inhibiting the activity of EGF-R PTK, or other crucial PTK's in vivo. Subsequent studies on intact tumor cell lines demonstrated that EGF-R and other growth factor receptors are able to transmit mitogenic signals in the presence of genistein. In fact, it is difficult to detect decreases in the tyrosine phosphorylation of discrete proteins after genistein treatment. Other mechanisms for the effect of genistein have been suggested from in vitro and cell culture data. Genistein not only inhibits the activity of purified topoisomerase II in vitro, but also leads to the accumulation of protein-associated single strand breaks in whole cells. Genistein also inhibits the production of reactive oxygen species which may lead to tissue damage and DNA modification. Additionally, genistein acts as a weak estrogen, modifies cellular differentiation programs, inhibits angiogenesis. modulates cell cycle events and may precipitate apoptosis. However, few of the above mechanisms in tumor cells are sensitive to the physiological serum concentrations of genistein (< 18.5 mumol/L, or < 5 micrograms/mL). Primary, nontransformed human mammary epithelial cells, which have a much greater sensitivity to genistein, would be a better system for the study of these mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Flavonoids: Prospective Drug Candidates
Cazarolli, L., Zanatta, L., Alberton, E., Bonorino Figueiredo, M. S., Folador, P., Damazio, R., Pizzolatti, M., & Barreto Silva, F. R. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369564 · Cited by 404
Cardiovascular and renal benefits of dry bean and soybean intake
Anderson, J. W., Smith, B. M., & Washnock, C. S. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.464s · Cited by 397
Phyto-oestrogens: where are we now?
Bingham, S. A., Atkinson, C., Liggins, J., Bluck, L., & Coward, A. (1998) · British Journal of Nutrition · doi:10.1079/bjn19980068 · Cited by 393
Murkies, A. L., Wilcox, G., & Davis, S. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4577 · Cited by 355
Intestinal Uptake and Biliary Excretion of the Isoflavone Genistein in Rats , ,
Sfakianos, J., Coward, L., Kirk, M., & Barnes, S. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.7.1260 · Cited by 328
Metadata
- Authors
- Peterson, G.
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 1995-03
- Volume
- 125
- Issue
- 3 Suppl
- Pages
- 784S-789S
- ISSN
- 0022-3166 (ISSN-L)
- OpenAlex
- W1908557305
- Cited by
- 196
- References
- 0
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of the Biochemical Targets of Genistein in Tumor Cells. https://app.cochat.ai/papers/10.1093/jn/125.suppl_3.784s
- The paper
- Peterson, G. (1995). Evaluation of the Biochemical Targets of Genistein in Tumor Cells. The Journal of Nutrition. https://doi.org/10.1093/jn/125.suppl_3.784s
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.